Tea consumption and epithelial ovarian cancer risk: A systematic review of observational studies

Nutrition and Cancer

Volumn 63, Issue 6, 2011, Pages 817-826

  Oppeneer, Sarah J ^a   Robien, Kim ^a,b  

^a UNIVERSITY OF MINNESOTA   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER PREVENTION; CANCER RISK; DIETARY INTAKE; DISEASE ASSOCIATION; FOOD FREQUENCY QUESTIONNAIRE; HUMAN; OBSERVATIONAL STUDY; OVARY CANCER; REVIEW; SYSTEMATIC REVIEW; TEA;

FEMALE; HUMANS; NEOPLASMS, GLANDULAR AND EPITHELIAL; OVARIAN NEOPLASMS; RISK FACTORS; TEA; UNITED STATES;

EID: 80051724606     PISSN: 01635581     EISSN: 15327914     Source Type: Journal    
DOI: 10.1080/01635581.2011.594210     Document Type: Review

References (40)

1. World Cancer Research Fund/American Institute for Cancer: Food, Nutrition, Physical Activity, and the Prevention of Cancer: A Global Perspective. American Institute for Cancer, Washington, DC, 2007.
2. National Cancer Institute: SEER Stat Fact Sheet: Ovarian Cancer 2009. http://seer.cancer.gov/statfacts/html/ovary.html. Accessed 2010 March 12.
3. Yang CS, Lambert JD, Ju J, Lu G, and Sang S: Tea and cancer prevention: Molecular mechanisms and human relevance. Toxicol Appl Pharmacol 224, 265-273, 2007.
4. Yang CS,Wang X, Lu G, and Picinich SC: Cancer prevention by tea: Animal studies, molecular mechanisms and human relevance. Nat Rev Cancer 9, 429-439, 2009.
5. Balentine DA: Manufacturing and chemistry of tea. In: Phenolic Compounds in Food and Their Health Effects, 2nd ed., Ho CHM and Lee C, eds. Washington, DC: American Chemical Society, 1992, pp. 102-117.
6. Balentine DA, Wiseman SA, and Bouwens LC: The chemistry of tea flavonoids. Crit Rev Food Sci Nutr 37, 693-704, 1997.
7. Yang CS, Sang S, Lambert JD, and LeeMJ: Bioavailability issues in studying the health effects of plant polyphenolic compounds. Mol Nutr Food Res 52(Suppl 1), S139-S151, 2008.
8. Lambert JD, Sang S, and Yang CS: Biotransformation of green tea polyphenols and the biological activities of those metabolites. Mol Pharm 4, 819-825, 2007.
9. Kao YH, Hiipakka RA, and Liao S: Modulation of endocrine systems and food intake by green tea epigallocatechin gallate. Endocrinology 141, 980-987, 2000.
10. Wu AH, Arakawa K, Stanczyk FZ, Van Den Berg D, Koh WP, et al.: Tea and circulating estrogen levels in postmenopausal Chinese women in Singapore. Carcinogenesis 26, 976-980, 2005.
11. Huh SW, Bae SM, Kim YW, Lee JM, Namkoong SE, et al.: Anticancer effects of (-)-epigallocatechin-3-gallate on ovarian carcinoma cell lines. Gynecol Oncol 94, 760-768, 2004.
12. Kim YW, Bae SM, Lee JM, Namkoong SE, Han SJ, et al.: Activity of green tea polyphenol epigallocatechin-3-gallate against ovarian carcinoma cell lines. Cancer Res Treat 36, 315-323, 2004.
13. Kotsopoulos J, Eliassen AH, Missmer SA, Hankinson SE, and Tworoger SS: Relationship between caffeine intake and plasma sex hormone concentrations in premenopausal and postmenopausal women. Cancer 115, 2765-2774, 2009.
14. Leonard TK,Watson RR, andMohs ME: The effects of caffeine on various body systems: A review. J Am Diet Assoc 87, 1048-1053, 1987.
15. da Costa Santos CM, de Mattos Pimenta CA, and Nobre MR: The PICO strategy for the research question construction and evidence search. Rev Lat Am Enfermagem 15, 508-511, 2007.
16. GatesMA,Tworoger SS, Hecht JL, DeVivo I, Rosner B, et al.:Aprospective study of dietary flavonoid intake and incidence of epithelial ovarian cancer. Int J Cancer 121, 2225-2232, 2007.
17. Larsson SC and Wolk A: Tea consumption and ovarian cancer risk in a population-based cohort. Arch Intern Med 165, 2683-2686, 2005.
18. Silvera SA, Jain M, Howe GR, Miller AB, and Rohan TE: Intake of coffee and tea and risk of ovarian cancer: A prospective cohort study. Nutr Cancer 58, 22-27, 2007.
19. Steevens J, Schouten LJ, Verhage BA, Goldbohm RA, and van den Brandt PA: Tea and coffee drinking and ovarian cancer risk: Results from the Netherlands Cohort Study and a meta-analysis. Br J Cancer 97, 1291-1294, 2007.
20. ZhengW, Doyle TJ, Kushi LH, Sellers TA, Hong CP, et al.: Tea consumption and cancer incidence in a prospective cohort study of postmenopausal women. Am J Epidemiol 144, 175-182, 1996.
21. Yen ML, Yen BL, Bai CH, and Lin RS: Risk factors for ovarian cancer in Taiwan: A case-control study in a low-incidence population. Gynecol Oncol 89, 318-324, 2003.
22. Byers T,Marshall J, Graham S, Mettlin C, and Swanson M: A case-control study of dietary and nondietary factors in ovarian cancer. J Natl Cancer Inst 71, 681-686, 1983.
23. Goodman MT, Tung KH, McDuffie K,Wilkens LR, and Donlon TA: Association of caffeine intake and CYP1A2 genotype with ovarian cancer. Nutr Cancer 46, 23-29, 2003.
24. Jordan SJ, Purdie DM, Green AC, and Webb PM: Coffee, tea, and caffeine and risk of epithelial ovarian cancer. Cancer Causes Control 15, 359-365, 2004.
25. Kuper H, Titus-Ernstoff L, Harlow BL, and Cramer DW: Population-based study of coffee, alcohol, and tobacco use and risk of ovarian cancer. Int J Cancer 88, 313-318, 2000.
26. La Vecchia C, Negri E, Franceschi S, D'Avanzo B, and Boyle P: Tea consumption and cancer risk. Nutr Cancer 17, 27-31, 1992.
27. Miller DR, Rosenberg L, Kaufman DW, Helmich SP, Schottenfeld D, et al.: Epithelial ovarian cancer and coffee drinking. Int J Epidemiol 16, 13-17, 1987.
28. Nagle CM, Olsen CM, Bain CJ, Whiteman DC, Green AC, et al.: Tea consumption and risk of ovarian cancer. Cancer Causes Control 21, 1485-1491, 2010.
29. Song YJ, Kristal AR, Wicklund KG, Cushing-Haugen KL, and Rossing MA: Coffee, tea, colas, and risk of epithelial ovarian cancer. Cancer Epidemiol Biomarkers Prev 17, 712-716, 2008.
30. Tavani A, Gallus S, Dal Maso L, Franceschi S, Montella M, et al.: Coffee and alcohol intake and risk of ovarian cancer: An Italian case-control study. Nutr Cancer 39, 29-34, 2001.
31. Zhang M, Binns CW, and Lee AH: Tea consumption and ovarian cancer risk: A case-control study in China. Cancer Epidemiol Biomarkers Prev 11, 713-718, 2002.
32. Byers T: Food frequency dietary assessment: How bad is good enough? Am J Epidemiol 154, 1087-1088, 2001.
33. Kristal AR, PetersU, and Potter JD: Is it time to abandon the food frequency questionnaire? Cancer Epidemiol Biomarkers Prev 14, 2826-2828, 2005.
34. Schatzkin A and Kipnis V: Could exposure assessment problems give us wrong answers to nutrition and cancer questions? J Natl Cancer Inst 96, 1564-1565, 2004.
35. Subar AF, Kipnis V, Troiano RP, Midthune D, Schoeller DA, et al.: Using intake biomarkers to evaluate the extent of dietary misreporting in a large sample of adults: The OPEN study. Am J Epidemiol 158, 1-13, 2003.
36. Zhang M, Holman CD, and Binns CW: Intake of specific carotenoids and the risk of epithelial ovarian cancer. Br J Nutr 98, 187-193, 2007.
37. Zhu BT: Catechol-O-methyltransferase (COMT)-mediated methylation metabolism of endogenous bioactive catechols and modulation by endobiotics and xenobiotics: Importance in pathophysiology and pathogenesis. Curr Drug Metab 3, 321-349, 2002.
38. Landis-Piwowar K, Chen D, Chan TH, and Dou QP: Inhibition of catechol- Omicron-methyltransferase activity in human breast cancer cells enhances the biological effect of the green tea polyphenol (-)-EGCG. Oncol Rep 24, 563-569, 2010.
39. National Center for Biotechnology Information: HapMap 2010. http:// hapmap.ncbi.nlm.nih.gov/index.html.en. Accessed 2010 November 9.
40. Dawling S, Roodi N, Mernaugh RL, Wang X, and Parl FF: Catechol-Omethyltransferase (COMT)-mediated metabolism of catechol estrogens: Comparison of wild-type and variant COMT isoforms. Cancer Res 61, 6716-6722, 2001.